07.12.2012 Views

Nottingham Galway - National University of Ireland, Galway

Nottingham Galway - National University of Ireland, Galway

Nottingham Galway - National University of Ireland, Galway

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Session 7: TREATMENT SELECTION<br />

Chaired by: Dr Cecily Quinn, Pr<strong>of</strong>essor Carsten Rose<br />

Panel: Mr Karl Sweeney, Dr Sinead Walsh, Ms Mairead Lyons<br />

2.00 Targeted Radiotherapy: Who / How<br />

Dr Joe Martin<br />

Consultant Radiologist, <strong>Galway</strong> <strong>University</strong> Hospital, <strong>Galway</strong>, <strong>Ireland</strong><br />

2.15 Experience with PB Radiation<br />

Pr<strong>of</strong>essor Frank Sullivan<br />

Pr<strong>of</strong>essor <strong>of</strong> Radiation Oncology, NUI <strong>Galway</strong>, <strong>Ireland</strong><br />

2.30 Selection for Hormone Responsiveness - Which Patients can Avoid Chemotherapy?<br />

Pr<strong>of</strong>essor Nigel Bundred<br />

Pr<strong>of</strong>essor in Surgical Oncology, <strong>University</strong> Hospital <strong>of</strong> South Manchester,<br />

Wythenshawe, UK<br />

2.45 Sentinel Node Biopsy and Neoadjuvant Therapy<br />

Mr Malcolm Kell<br />

Consultant Surgeon, BreastCheck, Dublin, <strong>Ireland</strong><br />

3.00 Screen Detected Lesions: Implications for Intervention<br />

Dr Margaret Sheehan<br />

Consultant Pathologist, BreastCheck West, <strong>Galway</strong> <strong>University</strong> Hospital,<br />

<strong>Galway</strong>, <strong>Ireland</strong><br />

3.15 Discussion<br />

3.30 C<strong>of</strong>fee<br />

Session 8: PROGNOSIS<br />

Chaired by: Pr<strong>of</strong>essor Paul Redmond, Pr<strong>of</strong>essor Mike Dixon<br />

Panel: Dr Paul Donnellan, Dr Cecily Quinn, Pr<strong>of</strong>essor Carsten Rose<br />

4.00 New Methods <strong>of</strong> Predicting Outcome using Adjuvant Online for Europe<br />

Pr<strong>of</strong>essor Gordon Wishart<br />

Consultant Breast & Endocrine Surgeon, Cambridge Breast Unit, Addenbrooke's<br />

Hospital, Cambridge, UK<br />

4.15 Twenty Years Experience with NPI<br />

Pr<strong>of</strong>essor Roger Blamey<br />

Emeritus Pr<strong>of</strong>essor (Surgery) and Consultant Surgeon, <strong>Nottingham</strong> <strong>University</strong><br />

Hospitals NHS Trust, UK<br />

4.30 Correlation <strong>of</strong> (International) BrCa long-term Mortality Trends with the<br />

Access to Cancer Care<br />

Pr<strong>of</strong>essor Joseph Ragaz<br />

Pr<strong>of</strong>essor <strong>of</strong> Medicine & Oncology, McGill <strong>University</strong>, Canada<br />

4.45 Outcome <strong>of</strong> Oncopool Study<br />

Pr<strong>of</strong>essor Michael Kerin<br />

Pr<strong>of</strong>essor <strong>of</strong> Surgery, NUI <strong>Galway</strong>, <strong>Galway</strong>, <strong>Ireland</strong><br />

5.00 Close <strong>of</strong> Meeting<br />

9

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!